http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0617617-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
filingDate 1992-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871d3bd69a58e0a10f27c20cbb256230
publicationDate 1994-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0617617-A1
titleOfInvention Compositions containing histamine-h2-receptor antagonists at low dosage
abstract Compositions for oral administration for the treatment of gastric disorders, comprising a histamine H2 receptor inhibitor and an antacid, and exposed to optimal buffering to promote local absorption of the H2 receptor inhibitor, which is present in a content of less than 25 mg per unit dosage form.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102011083984-A1
priorityDate 1991-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449760797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129307185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21906954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453426087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453694953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11397538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453459427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448783041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129741655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61680
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCEAW61369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449114590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454570538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450553376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9883333

Total number of triples: 89.